Chimeron Bio Corp — Form D

Chimeron Bio Corp of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-30. The offering totals $10.0M, of which $1.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
Gorka FiusDirectorCambridge, MA
Thimmaiah ChendrimadaExecutive OfficerPhiladelphia, PA
Antonin de FougerollesDirectorPhiladelphia, PA
Monica ColemanExecutive OfficerPhiladelphia, PA
Kevin HeyeckDirectorPhiladelphia, PA
Kevin HeyeckExecutive OfficerPhiladelphia, PA
Afshin SafaviDirectorPhiladelphia, PA
Hemanshu PandyaDirectorNEW YORK, NY
Thimmaiah ChendrimadaDirectorPhiladelphia, PA
Thimmaiah ChendrimadaPromoterPhiladelphia, PA
Chiraag PatelDirectorPhiladelphia, PA
Jolly MazmudarDirectorPhiladelphia, PA
Jolly MazmudarExecutive OfficerPhiladelphia, PA
Jolly MazmudarPromoterPhiladelphia, PA
Monica Dilip ColemanExecutive OfficerPhiladelphia, PA
Afshin Dilip SafaviDirectorPhiladelphia, PA
Chiraag Dilip PatelDirectorPhiladelphia, PA
Hemanshu Dilip PandyaDirectorPhiladelphia, PA

Other filings by this issuer (4)

FiledFormOfferingSold
2025-03-14D/A$12.8M
2025-03-03D$13.7M
2022-03-10D$3.0M$782K
2020-12-28D$5.0M$300K

More